Press releases
- Accuray to Participate in the Jefferies Global Healthcare Conference 2024
- Accuray Reports Fiscal 2024 Third Quarter Financial Results
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
- New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
- Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.40 |
---|---|
High | 1.41 |
Low | 1.38 |
Bid | 1.40 |
Offer | 1.42 |
Previous close | 1.42 |
Average volume | 111.60 |
---|---|
Shares outstanding | 99.24m |
Free float | 95.42m |
P/E (TTM) | -- |
Market cap | 151.84m USD |
EPS (TTM) | -0.2197 USD |
Data delayed at least 15 minutes, as of May 22 2024.
More ▼